← Back to headlines
Cynosure Lutronic Gains Regulatory Approvals in China and Japan for Clarity II™
Cynosure Lutronic has strengthened its presence in the APAC region, the fastest-growing market for medical aesthetics devices, by securing dual regulatory approvals for its Clarity II™ product in China and Japan, effective February 2026.
27 Feb, 10:12 — 27 Feb, 10:12
ℹOnly 1 source covers this story
Related Stories
DOTr chief targets partial launch of DPTMP by Q4 2027
just now
Tropic Maloprodaja and Disability Associations Launch Parking Protection Campaign in BiH
3m ago
Nigeria Seeks Canadian Tech and Investment for Mining Reforms
5m ago
Serbia Sees Slight Increase in Tourist Arrivals and Overnight Stays in January
6m ago